Quarter Ending 2026-06-30
During the quarter ending 2026-06-30, Cincinnati Financial Corp made a series of notable adjustments to its equity portfolio. The firm initiated a new stake in Honeywell Aerospace Ord worth $92,577,250, while simultaneously opening a fresh Honeywell International Ord position valued at $93,758,125 after exiting a prior Honeywell International Ord holding that had been worth $189,300,125. A smaller new position was also opened in Xylem Ord, valued at $14,563,472, and the fund fully exited its Lam Research Ord stake, previously worth $31,621,680.
Several existing technology and industrial holdings were increased. Cisco Systems Ord rose 51%, Qualcomm Ord climbed 43%, and Analog Devices Ord grew 25%. Microchip Technology Ord increased 41%, while Apple Ord expanded 14% to reach $809,344,550. Outside tech, UnitedHealth Grp Ord grew 54%, AbbVie Ord rose 16%, Philip Morris International Ord gained 9%, Dover Ord added 8%, and Snap On Ord increased 11%.
On the reduction side, Broadcom Ord was trimmed 11%, CME Group Cl A Ord fell 25%, and US Bancorp Ord dropped sharply by 64%. Accenture Cl A Ord decreased 37%, and McDonald’s Ord declined 13%.
These portfolio changes reflect Cincinnati Financial Corp’s ongoing rebalancing activity during the quarter ending 2026-06-30. This report is for informational purposes only and should not be interpreted as investment advice.
Cincinnati Financial Corp’s portfolio moves, tracked quarter by quarter, as disclosed in the insurer’s SEC Form 13F filings. This profile follows how the company’s equity holdings shift over time, giving a running view of where capital is being added, trimmed, or walked away from entirely. Because 13F filings only report a quarterly snapshot rather than exact trade dates, all moves below are described as occurring during the quarter ending 2026-03-31, and future updates will build on this same record.
New Positions and Exits
Cincinnati Financial Corp opened three new positions during the quarter ending 2026-03-31: Thermo Fisher Scientific ($38,324,594), Lam Research ($31,621,680), and SouthState Bank ($18,542,766). Notably, Lam Research was also fully exited during the same quarter, with a previously held stake worth $47,457,943 closed out, suggesting the earlier position was sold down before a new one was established. Pfizer was exited as well, with a position previously worth $12,123,212 removed from the portfolio entirely.
Increases and Reductions
Several existing holdings were built up further. Valero Energy rose 52%, from $83,778,246 to $127,157,251, the largest percentage increase of the quarter. Honeywell International grew 16% to $189,300,125, Analog Devices climbed 17% to $141,849,082, and CME Group Class A shares increased 8% to $295,940,700. Smaller additions came from Dover (up 7% to $175,848,420), Pinnacle West (up 14% to $73,493,095), Arthur J Gallagher (up 17% to $56,583,474), and Johnson & Johnson (up 18% to $49,132,440).
On the other side, several long-standing positions were reduced in size. Broadcom saw the steepest cut, down 25% from $596,991,005 to $446,826,897, matched by an identical 25% reduction in Qualcomm, down to $123,306,850. Microsoft was trimmed 23% to $181,808,996, Accenture Class A fell 26% to $67,022,020, UnitedHealth Group dropped 18% to $126,858,545, and Automatic Data Processing declined 21% to $47,290,145. Apple, the largest position referenced this quarter, was reduced by a smaller 7%, moving from $760,396,770 to $709,854,691.
Taken together, the quarter ending 2026-03-31 shows a portfolio being reshaped rather than dramatically overhauled, with fresh capital directed toward new names like Thermo Fisher Scientific and SouthState Bank, continued conviction in energy and industrial names like Valero and Honeywell, and lighter weighting across several large technology and healthcare holdings. This page will be updated each quarter as new 13F data becomes available, allowing readers to follow Cincinnati Financial Corp’s institutional positioning as it develops over time. Nothing here should be read as a recommendation to buy or sell any of the securities mentioned.
Source: SEC Form 13F filings. This page updates every quarter.